Professor Atul Gupta is Professor of Paediatric Respiratory Medicine at King’s College London and Consultant Respiratory Paediatrician at King’s College Hospital, where he leads the Children’s Respiratory Service and is Research and Innovation Lead for Child Health. He is Clinical Lead for the South-East London Asthma Network, serves on the Respiratory Clinical Speciality Advisory Committee at the Royal College of Paediatrics and Child Health, and is Audit and Quality Lead for the British Paediatric Respiratory Society. His research focuses on children with complex and life-limiting respiratory conditions, including studies on severe asthma, respiratory infections, and vitamin D in disease prevention. He has over 175 publications and has received awards. He has received several prestigious awards, including the Lorber Prize (RCPCH), the James Fellowship (BMA), the VASR Memorial Gold Medal, the S.S. Manchanda Research Gold Medal, and Dr Somu Oration Award.

Prof. Jonathan Grigg’s research focuses on the adverse effects of particulate matter air pollution on children’s respiratory health. He has also performed independent randomised controlled trials of asthma therapies, and led a Global Health Research Group focused on improving asthma control in children living in Sub Sharan Africa. He co-chaired Royal College of Physicians’ reports on the effects of outdoor and indoor air pollution, and was Head of the European Respiratory Society’s Tobacco Control Committee and its Paediatric Assembly.  

Born & raised in Canada; obtained MD from University of Toronto, completed a pediatric residency at University of Ottawa, and pediatric respiratory medicine fellowship at McGill University in Montreal. Career began as Assistant Professor of Pediatrics & Child Health at University of Manitoba, then Associate Professor at Dalhousie University where I was granted tenure. After practicing in Canada for 15 years, I relocated to Mayo Clinic where I practiced another 12 years, becoming Full Professor in Pediatric & Adolescent Medicine. After brief time at King’s College Hospital from April 2017, returned to the USA in July 2018, as Professor of Pediatrics at the University of MN. I was thoroughly schooled in respiratory physiology during my fellowship at McGill University and the renowned Meakins-Christie Lab. My initial research during fellowship studied with sickle cell disease as a model for oxygen delivery during exercise. I subsequently studied control of breathing during exercise in health and in children with cystic fibrosis. I developed pictorial scales to measure dyspnea and perceived exertion in children during exercise as I studied ventilatory strategy during exercise in healthy children and adolescents. My showpiece publication with ~300 citations is the report that not only peakO2, but also its rate of decline is associated with mortality in cystic fibrosis. Most recently, I collaborated with biomedical engineers here at UMN to develop a prototype for ambulatory measurement of thoraco-abdominal movement with resolution of 1 mm in x-y-z planes, in order to track breathing without facial interface.

Mira Osinibi is a Paediatric Respiratory Clinical Nurse Specialist at King’s College Hospital, where she has worked for over ten years. She specialises in smoking and vaping cessation in children and young people and is widely recognised for her expertise in the harms of vaping among adolescents. Mira delivers evidence-based education on vaping harms to secondary school pupils, teachers, and parents, including virtual sessions for families. She also provides professional teaching to NHS Trusts, Asthma Networks, medical associations, and the British Society of Paediatric Dentistry. As a member of the Campaign for Children’s Lung Health (CCLH), Mira actively contributes to national advocacy supporting the UK Tobacco and Vape Bill and promoting lung health in children. She is the author of publications in The Lancet Respiratory Medicine and The European Journal of Paediatrics and has been interviewed by The Guardian and The Sun on her clinical insights into vaping harms in adolescents. 

Dr. Amine Daher completed his subspecialty training in Pediatric Pulmonology at the University of Texas Southwestern in Dallas, Texas and subspecialty training in Sleep Medicine at Baylor College of Medicine in Houston, Texas. Dr Daher is certified by the American Board of Pediatrics  in General Pediatrics, Pediatric Pulmonology, and in Sleep Medicine. He currently is a consultant in pediatric pulmonology and sleep medicine at AlJalila Children's Hospital in Dubai. Dr. Daher has previously served as the medical director of the Pediatric Chronic Tracheostomy and Ventilator program at the University of New Mexico and was responsible for the care of all pediatric ventilator dependent children in the state. He also worked at Driscoll Children’s Hospital in Corpus Christi, Texas, as consultant in pediatric pulmonology and sleep medicine and was the Founding Medical Director of the Driscoll Pediatric Sleep Center. A sleep center he built from the ground up and was successful in rapidly achieving accreditation from the American Academy of Sleep Medicine (AASM).

Dr. Mujtaba is a Consultant Pediatric Pulmonologist with 20 years of experience in pediatrics and pediatric pulmonology. Currently working at Burjeel Medical city in Abu Dhabi for last 3 years where he has set up Bronchoscopy and sleep service for children. He has previously worked in prestigious institutions in UK and Ireland. At Royal Manchester Children’s Hospital, where he was clinical lead. Dr. Mujtaba developed various guidelines both for CF and respiratory service. He has presented at ERS and CF Conferences and participated in national and international clinical trials in the UK and Ireland as Principal Investigator. He was a clinical and educational supervisor in the UK. Dr. Mujtaba has also been an honorary clinical lecturer and academic advisor for medical students at the University of Manchester.